Advisory Committee on Breast Cancer in Young Women (ACBCYW), 76592 [2016-26569]
Download as PDF
<![CDATA[
76592
Federal Register / Vol. 81, No. 213 / Thursday, November 3, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 1:00 p.m.–5:00 p.m.
EST, December 13, 2016.
Place: This meeting will be held via
Teleconference and web access.
Teleconference and web access login
information is as follows:
Toll-Free Telephone: 1–888–566–
6510, Participant passcode: 3895011.
Net Conference and Web Url: https://
www.mymeetings.com/nc/join/.
Conference number: PWXW1545545,
Audience passcode: 3895011.
Participants can join the event
directly at: https://
www.mymeetings.com/nc/join.php?
i=PWXW1545545&p=3895011&t=c.
WebEx Required Download:
Participants must have the WebEx Event
Manager installed prior to joining the
web portion of the meeting.
Status: Open to the public, limited
only by the audio phone lines and net
conference access available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters for Discussion: The agenda
will include discussions on the current
and emerging topics related to breast
cancer in young women. These will
include public health communication,
breast cancer in young women digital
and social media campaigns, and CDC
updates. Committee workgroups will
report findings to the committee.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 3
business days in advance at https://
VerDate Sep<11>2014
17:54 Nov 02, 2016
Jkt 241001
www.cdc.gov/cancer/breast/what_cdc_
is_doing/meetings.htm. Please complete
all the required fields before submitting
your registration and submit no later
than December 8, 2016.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 5770 Buford Hwy, NE.,
Mailstop K52, Atlanta, Georgia 30341,
Telephone (770) 488–4518, Fax (770)
488–4760. Email: acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–26569 Filed 11–2–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17BZ]; Docket No. CDC–2016–
0104]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Project
Pride.’’ This project is funded by CDC
at 12 health departments in the United
States. The health departments will
report standardized program monitoring
and evaluation (M&E) data to CDC. CDC
is requesting approval to collect
standardized HIV prevention program
evaluation data from funded health
departments.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Written comments must be
received on or before January 3, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0104 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
DATES:
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Page 76592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26569]
[[Page 76592]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 1:00 p.m.-5:00 p.m. EST, December 13, 2016.
Place: This meeting will be held via Teleconference and web access.
Teleconference and web access login information is as follows:
Toll-Free Telephone: 1-888-566-6510, Participant passcode: 3895011.
Net Conference and Web Url: https://www.mymeetings.com/nc/join/.
Conference number: PWXW1545545, Audience passcode: 3895011.
Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PWXW1545545&p=3895011&t=c.
WebEx Required Download: Participants must have the WebEx Event
Manager installed prior to joining the web portion of the meeting.
Status: Open to the public, limited only by the audio phone lines
and net conference access available.
Purpose: The committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters for Discussion: The agenda will include discussions on the
current and emerging topics related to breast cancer in young women.
These will include public health communication, breast cancer in young
women digital and social media campaigns, and CDC updates. Committee
workgroups will report findings to the committee.
Agenda items are subject to change as priorities dictate.
Online Registration Required: All ACBCYW Meeting participants must
register for the meeting online at least 3 business days in advance at
https://www.cdc.gov/cancer/breast/what_cdc_is_doing/meetings.htm. Please
complete all the required fields before submitting your registration
and submit no later than December 8, 2016.
Contact Person for More Information: Temeika L. Fairley, Ph.D.,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 5770 Buford Hwy, NE., Mailstop
K52, Atlanta, Georgia 30341, Telephone (770) 488-4518, Fax (770) 488-
4760. Email: acbcyw@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-26569 Filed 11-2-16; 8:45 am]
BILLING CODE 4163-18-P
